Akorn, Inc.
Pharmaceutical firm reports 25% increase in revenues
Published in Pharma Investments, Ventures and Law Weekly, September 19th, 2004
Revenues were $11.1 million for the second quarter, a 25% increase compared to revenues of $8.8 million for the second quarter of 2003. Net loss for the quarter decreased 14% to $3.6 million, or $0.18 per diluted share as compared to $4.2 million, or $0.21 for the comparable period last year.
For the 6 months ended June 30, 2004, revenue increased 5% to $22.7 million. Net loss was $4.8 million, or $0.24 per diluted share, a 20% increase from the $4.0 million, or $0.20 per diluted share, in 2003. The increase in net loss is primarily attributable to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Access Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $0.17 per share - Albany Molecular Research, Inc.
Drug discovery firm reports 22.2% decrease in revenues - Alkermes, Inc.
Pharmaceutical firm reports loss of $0.40 per share - America Oriental Bioengineering
Chinese biotech firm reports 23% revenue increase - Anadys Pharmaceuticals, Inc.
Hepatitis drug maker reports loss of $0.50 per share - Antares Pharma, Inc.
Pharmaceutical firm reports 24% decrease in revenue - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
